IRONWOOD PHARMACEUTICALS, INC. Hedging Liabilities, Noncurrent
IRONWOOD PHARMACEUTICALS, INC. (IRWD) had Hedging Liabilities, Noncurrent of $11.06 million as of 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:HedgingLiabilitiesNoncurrent · last filed 2022-02-18
- 2021-06-30: Hedging Liabilities, Noncurrent $11.06M.
- 2021-03-31: Hedging Liabilities, Noncurrent $7.98M.
- 2020-12-31: Hedging Liabilities, Noncurrent $12.09M.
- 2020-09-30: Hedging Liabilities, Noncurrent $7.70M.
| Period end | Hedging Liabilities, Noncurrent |
|---|---|
| 2021-06-30 | $11.06M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $7.98M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $12.09M 10-K · filed 2022-02-18 |
| 2020-09-30 | $7.70M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $12.96M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $12.21M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $24.26M 10-K · filed 2021-02-17 |
| 2019-09-30 | $8.77M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $50.19M 10-Q · filed 2019-07-30 |
| 2019-03-31 | $39.39M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $33.76M 10-K · filed 2020-02-13 |
| 2018-09-30 | $122.78M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $143.02M 10-Q · filed 2018-08-06 |
| 2018-03-31 | $96.13M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $92.19M 10-K · filed 2019-02-25 |
| 2017-09-30 | $103.74M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $149.46M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $133.42M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $113.24M 10-K · filed 2018-02-22 |
| 2016-09-30 | $120.12M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $86.84M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $68.19M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $75.33M 10-K · filed 2017-02-22 |
| 2015-09-30 | $62.98M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $69.46M 10-Q · filed 2015-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |